Home > Press > Lumera Corporation to Exhibit at PEGS in Boston May 14-18
Abstract:
The Protein Engineering Summit
Lumera Corporation to Exhibit at PEGS in Boston May 14-18
BOTHELL, WA | Posted on May 7th, 2007
Lumera Corporation (NASDAQ:LMRA), a leader in the emerging field of nanotechnology, announced today that it will be exhibiting at the Protein Engineering Summit 2007 (PEGS). The conference is being held in Boston and begins on Monday, May 14, 2007, and continues through Friday, May 18, 2007.
In addition, Ron Dudek, Lumera's Director of Business Development, will be giving a luncheon workshop presentation on Monday, May 14, entitled "Surface Plasmon Resonance (SPR) Analysis of High-Density Antibody Microarrays: Combining Antibody Screening and Kinetic Characterization in One Platform." Additional information on the conference can be obtained at http://www.pegsummit.com/ .
####
About Lumera Corporation
Lumera is a leader in the emerging field of nanotechnology. The company designs proprietary molecular structures and polymer compounds for the bioscience and communications/computing industries, both of which represent large market opportunities. The company also has developed proprietary processes for fabricating such devices. For more information, please visit http://www.lumera.com .
Certain statements contained in this release are forward-looking statements that involve a number of risks and uncertainties. Factors that could cause actual results to differ materially from those projected in the company’s forward-looking statements include the following: market acceptance of our technologies and products; our ability to obtain financing; our financial and technical resources relative to those of our competitors; our ability to keep up with rapid technological change; government regulation of our technologies; our ability to enforce our intellectual property rights and protect our proprietary technologies; the ability to obtain additional contract awards and to develop partnership opportunities; the timing of commercial product launches; the ability to achieve key technical milestones in key products; and other risk factors identified from time to time in the company’s SEC reports, including its Annual Report on Form 10-K, and its Quarterly Reports on Form 10-Q.
For more information, please click here
Contacts:
The Summit Group Communications
Todd Wolfenbarger
801-595-1155
Cell: 801-244-9600
Copyright © Business Wire 2007
If you have a comment, please
Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Bookmark:
Announcements
Whirlpools on the Nanoscale Could Multiply Magnetic Memory: At the Advanced Light Source, Berkeley Lab scientists join an international team to control spin orientation in magnetic nanodisks May 22nd, 2013
Bacterial spare parts filter antibiotic residue from groundwater May 22nd, 2013
UofL scientists uncover how grapefruits provide a secret weapon in medical drug delivery May 22nd, 2013
Atomic-Scale Investigations Solve Key Puzzle of LED Efficiency: MIT and Brookhaven Lab scientists use electron microscopy imaging techniques to settle a solid-state controversy and raise new experimental possibilities May 22nd, 2013
Events/Classes
Bacterial spare parts filter antibiotic residue from groundwater May 22nd, 2013
Xmark Media announces the 2013 Vacuum Expo & Vacuum Symposium, Ricoh Arena - Coventry 16-17 October May 21st, 2013
Iran to Hold 1st Conference on Applications of Nanotechnology in Energy Industry May 21st, 2013
Elsevier Business Intelligence (EBI) to Host 'IN3 Medical Device 360 Boston,' June 24-26, 2013 May 20th, 2013